| 1. |
Okumura F, Okumura Joo A, Obara K, Petersen A, Nishikimi A, Fukui Y, Nakatsukasa K, Kamura T, Ubiquitin ligase SPSB4 diminishes cell repulsive responses mediated by EphB2., Mol Biol Cell , 28, 24, 3532-3541, 28(24):3532-3541, 2017.11. |
| 2. |
Okumura F, Okumura Joo A, Nakatsukasa K, Kamura T, Hypoxia-inducible factor-2α stabilizes the von Hippel-Lindau (VHL) disease suppressor, Myb-related protein 2., PLoS One, 12, 4, 12(4):e0175593. 21,, 2017.04. |
| 3. |
Uematsu K, Okumura F, Tonogai S, Joo-Okumura A, Alemayehu DH, Nishikimi A, Fukui Y, Nakatsukasa K, Kamura T, ASB7 regulates spindle dynamics and genome integrity by targeting DDA3 for proteasomal degradation., The Journal of Cell Biology, 215, 1, 95-106, 215(1), 95-106, 2016.10. |
| 4. |
Okumura F, Uematsu K, Byrne SD, Hirano M, Joo-Okumura A, Nishikimi A, Shuin T, Fukui Y, Nakatsukasa K, Kamura T, Parallel Regulation of von Hippel-Lindau Disease by pVHL-Mediated Degradation of B-Myb and Hypoxia-Inducible Factor alpha., Molecular and Cellular Biology, 36, 12, 1803-1817, 36(12), 1803-1817, 2016.05. |
| 5. |
Okumura F, Joo-Okumura A, Nakatsukasa K, Kamura T, The role of cullin 5-containing ubiquitin ligases., Cell Division, 11, 1, , 2016.03, (2016) The role of cullin 5-containing ubiquitin ligases Cell Division, 11, 1, . |
| 6. |
Okumura F, Okumura AJ, Uematsu K, Hatakeyama S, Zhang DE, Kamura T, Activation of double-stranded RNA-activated protein kinase (PKR) by interferon-stimulated gene 15 (ISG15) modification down-regulates protein translation., Journal of Biological Chemistry, 288, 4, 2839-2847, 288(4):2839-2847, 2013.01. |
| 7. |
Shia WJ, Okumura Joo A, Yan M, Sarkeshik A, Lo MC, Matsuura S, Zhao X, Nimer SD, Yates JR, Zhang DE, PRMT1 interacts with AML1-ETO to promote its transcriptional activation and progenitor cell proliferative potential.
, Blood , 119, 21, 4953-4962, 119(21):4953-62, 2012.05. |
| 8. |
Okumura F, Okumura AJ, Matsumoto M, Nakayama KI, Hatakeyama S, TRIM8 regulates Nanog via Hsp90beta-mediated nuclear translocation of STAT3 in embryonic stem cells., Biochimica et Biophysica Acta, 1813, 10, 1784-1792, 1813(10), 1784-1792, 2011.10. |
| 9. |
Suizu F, Hiramuki Y, Okumura F, Matsuda M, Okumura Joo A, Hirata N, Narita M, Kohno T, Yokota J, Bohgaki M, Obuse C, Hatakeyama S, Obata T, Noguchi M, The E3 ligase TTC3 facilitates ubiquitination and degradation of phosphorylated Akt.
, Dev Cell , 17, 6, 800-810, 2009.12. |
| 10. |
Gardini A, Cesaroni M, Luzi L, Okumura Joo A, Biggs JR, Minardi SP, Venturini E, Zhang DE, Pelicci PG, Alcalay M, AML1/ETO Oncoprotein is directed to AML1 binding regions and co-localizes with AML1 and HEB on its targets., PLoS Genet, 4, 11, e1000275- , 4(11): e1000275, 2008.11. |
| 11. |
Okumura Joo A, Peterson LF, Okumura F, Boyapati A, Zhang DE, t(8;21)(q22;q22) fusion proteins preferentially bind to duplicated AML1/RUNX1 DNA binding sequences to differentially regulate gene expression., Blood , 112, 4, 1392-1401, 112(4): 1392-401, 2008.08. |
| 12. |
Peterson LF, Lo MC, Okumura Joo A, and Zhang DE, Inability of RUNX1/AML1 to breach AML1-ETO block of embryonic stem cell definitive hematopoiesis.
, Blood Cells Mol Dis, 39, 3, 321-328, 39(3): 321-8, 2007.11. |
| 13. |
Okumura Joo A, Peterson LF, Lo MC, Zhang DE, Expression of AML/Runx and ETO/MTG family members during hematopoietic differentiation of embryonic stem cells., Exp Hematol, 35, 6, 978-998, 35(6): 978-988, 2007.06. |
| 14. |
Okumura Joo A, Hatsuzawa K, Tamura T, Nagaya H, Saeki K, Okumura F, Nagao K, Nishikawa M, Yoshimura A, Wada I, Involvement of a Novel Q-SNARE, D12, in Quality Control of the Endomembrane System., J Biol Chem, 281, 7, 4495-4506, 281(7): 4495–4506, 2006.02. |
| 15. |
Yoshida T, Ogata H, Kamio M, Joo A, Shiraishi H, Tokunaga Y, Sata M, Nagai H, Yoshimura A, SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis., J Exp Med, 199, 2, 1701-1707, 199 (12): 1701–1707, 2004, 2004.06. |
| 16. |
Joo A, Aburatani H, Morii E, Iba H, Yoshimura A, STAT3 and MITF cooperatively induce cellular transformation through upregulation of c-fos expression., Oncogene, 23, 3, 726-734, 23(3): 726-34, 2004.01. |
| 17. |
Minoguchi M, Minoguchi S, Aki D, Joo A, Yamamoto T, Yumioka T, Matsuda T, Yoshimura A, STAP-2/BKS, an adaptor/docking protein, modulates STAT3 activation in acute-phase response through its YXXQ motif., J Biol Chem, 278, 13, 11182-11189, 278(13): 11182-9, 2003.03. |
| 18. |
Yamada S, Shiono S, Joo A, Yoshimura A, Control mechanism of JAK/STAT signal :transduction pathway., FEBS Lett, 534, 1-3, 190-196, 2003.01,
. |
| 19. |
Endo T, Sasaki A, Minoguchi M, Joo A, Yoshimura A, CIS1 interacts with the Y532 of the prolactin receptor and suppresses prolactin-dependent STAT5 activation., J.Biochem (Tokyo) , 133, 1, 109-113, 133(1): 109-13, 2003.01. |
| 20. |
Tani A, Kikuta R, Itoh K, Joo A, Shibata H, Ninomiya H, Tashiro N, and Fukumaki Y, Polymorphism analysis of the upstream region of the human N-methyl-D-aspartate receptor subunit NR1 gene (GRIN1): implications for schizophrenia., Schizophr Res, 58, 1, 83-86, 58(1): 83-6, 2002.11,
. |
| 21. |
Shibata H, Joo A, Fujii Y, Tani A, Makino C, Hirata N, Kikuta R, Ninomuya H, Tashiro N, Fukumaki Y, Association study of polymorphisms in the GluR5 kainate receptor gene (GRIK1) with schizophrenia. , Psychiatr Genet, 11, 3, 139-144, 11(3): 139-44, 2001, 2001.09,
. |
| 22. |
Joo A, Shibata H, Ninomiya H, Kawasaki H, Tashiro N, Fukumaki Y, Structure and polymorphisms of the human metabotropic glutamate receptor type 2 gene (GRM2): analysis of association with schizophrenia., Mol Psychiatry, 2, 186-192, 2: 186-92, 2001.03. |
